QuickVue At-Home
Device
Quidel Corporation
Total Payments
$619,924
Transactions
21
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $46,910 | 1 | 0 |
| 2021 | $573,014 | 20 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $619,924 | 21 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| QuickVue at Home | Quidel Corporation | $549,939 | 0 |
| Flu+SARS Validation Study | Quidel Corporation | $46,910 | 0 |
| SARS | Quidel Corporation | $23,075 | 0 |
Top Doctors Receiving Payments for QuickVue At-Home
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Vienna, VA | $619,924 | 21 |
Ad
Manufacturing Companies
- Quidel Corporation $619,924
Product Information
- Type Device
- Total Payments $619,924
- Total Doctors 0
- Transactions 21
About QuickVue At-Home
QuickVue At-Home is a device associated with $619,924 in payments to 0 healthcare providers, recorded across 21 transactions in the CMS Open Payments database. The primary manufacturer is Quidel Corporation.
Payment data is available from 2021 to 2022. In 2022, $46,910 was paid across 1 transactions to 0 doctors.
The most common payment nature for QuickVue At-Home is "Unspecified" ($619,924, 100.0% of total).
QuickVue At-Home is associated with 3 research studies, including "QuickVue at Home" ($549,939).